In the United States, SLE remains associated with substantial mortality, particularly among Non-Hispanic Black women.

It's more important than ever before for your elected officials to hear from you - don't miss your chance to turn Capitol Hill purple at the 2026 National Lupus Advocacy Summit this April!

Several social determinants of health were associated with increased risks for organ damage and mortality among patients newly diagnosed with SLE.

As The European Lupus Society’s 15th annual soiree approaches, the Clinical Trials Arena team takes a look at four promising therapies in the SLE pipeline.

Data suggest incidence and prevalence of systemic lupus erythematosus (SLE) vary widely among regions, although the authors noted some regions have been studied more extensively than others. A new ...

Skin manifestations are common in patients with SLE. A recent study reported increased site-specific recurrence of cutaneous lupus erythematosus (CLE).1 While this study included a proportion of ...

The research shows a disease-specific quality-of-life (QOL) tool is more sensitive than a generic version. A new study shows different medications for systemic lupus erythematosus (SLE) have different ...

Please provide your email address to receive an email when new articles are posted on . “Due to early meticulous diagnosis and the progress of treatment, survival rates for SLE patients have increased ...

A growth in the systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the 7MM is anticipated, as per ...